{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "european-medicines-agency", "type": "definition", "offset": [10, 35]}, {"key": "successor-agency", "type": "clause", "offset": [44, 60]}], "samples": [{"hash": "5xf93kGrhEg", "uri": "/contracts/5xf93kGrhEg#emea", "label": "Exclusive License Agreement (NantKwest, Inc.)", "score": 32.0499649048, "published": true}, {"hash": "cCqwDzsEOb5", "uri": "/contracts/cCqwDzsEOb5#emea", "label": "Process Development and Manufacturing Services Agreement", "score": 31.3408622742, "published": true}, {"hash": "cFk0EucoGSV", "uri": "/contracts/cFk0EucoGSV#emea", "label": "Collaboration and License Agreement (Pozen Inc /Nc)", "score": 25.7227916718, "published": true}], "snippet": "means the European Medicines Agency, or any successor agency thereto.", "size": 467, "hash": "80d64a772e46a48476c24791cced2b5d", "id": 1}, {"snippet_links": [{"key": "the-evaluation", "type": "clause", "offset": [30, 44]}, {"key": "medicinal-products", "type": "definition", "offset": [48, 66]}], "samples": [{"hash": "7lcszLEq4nc", "uri": "/contracts/7lcszLEq4nc#emea", "label": "License Agreement (Invea Therapeutics, Inc)", "score": 36.9534568787, "published": true}, {"hash": "7RTrKp7ElAt", "uri": "/contracts/7RTrKp7ElAt#emea", "label": "License Agreement (Invea Therapeutics, Inc)", "score": 36.1868591309, "published": true}, {"hash": "dzQOj1u3nR9", "uri": "/contracts/dzQOj1u3nR9#emea", "label": "License Agreement (Invea Therapeutics, Inc)", "score": 34.5961685181, "published": true}], "snippet": "means the European Agency for the Evaluation of Medicinal Products.", "size": 224, "hash": "53ff9f3d60fe4ede2eb7927ff60a3418", "id": 2}, {"snippet_links": [{"key": "european-medicines-agency", "type": "definition", "offset": [10, 35]}], "samples": [{"hash": "jk5qIUa50Uy", "uri": "/contracts/jk5qIUa50Uy#emea", "label": "Agreement and Plan of Merger (Evofem Biosciences, Inc.)", "score": 35.5434646606, "published": true}, {"hash": "19oYUNLPH6n", "uri": "/contracts/19oYUNLPH6n#emea", "label": "Agreement and Plan of Merger (Aditxt, Inc.)", "score": 35.5434646606, "published": true}, {"hash": "gQvf26hcPaR", "uri": "/contracts/gQvf26hcPaR#emea", "label": "Merger Agreement (Evofem Biosciences, Inc.)", "score": 34.9438743591, "published": true}], "snippet": "means the European Medicines Agency.", "size": 142, "hash": "0416a758ac5cf87ad0508074a0e409c4", "id": 3}, {"snippet_links": [{"key": "evaluation-agency", "type": "definition", "offset": [29, 46]}, {"key": "review-of", "type": "clause", "offset": [107, 116]}, {"key": "pharmaceutical-products", "type": "definition", "offset": [123, 146]}, {"key": "licensing-procedures", "type": "clause", "offset": [169, 189]}, {"key": "european-community", "type": "definition", "offset": [197, 215]}], "samples": [{"hash": "hKny2uiGHJA", "uri": "/contracts/hKny2uiGHJA#emea", "label": "Collaborative Development and License Agreement (Immunogen Inc)", "score": 27.8418884277, "published": true}, {"hash": "9lq1awlOjh0", "uri": "/contracts/9lq1awlOjh0#emea", "label": "Marketing, Distribution and Development Agreement (Gilead Sciences Inc)", "score": 21.0, "published": true}, {"hash": "2NZsNDksxwU", "uri": "/contracts/2NZsNDksxwU#emea", "label": "Collaborative Development and License Agreement (Immunogen Inc)", "score": 21.0, "published": true}], "snippet": "means the European Medicines Evaluation Agency, or any successor thereto, which coordinates the scientific review of human pharmaceutical products under the centralized licensing procedures of the European Community.", "size": 57, "hash": "61e0d5eec49bfb45fcd1303d7c667998", "id": 4}, {"snippet_links": [{"key": "evaluation-agency", "type": "definition", "offset": [29, 46]}, {"key": "successor-entity", "type": "clause", "offset": [54, 70]}, {"key": "the-european-union", "type": "clause", "offset": [82, 100]}, {"key": "provided-that", "type": "clause", "offset": [102, 115]}, {"key": "regulatory-approval", "type": "definition", "offset": [134, 153]}, {"key": "the-product", "type": "definition", "offset": [158, 169]}, {"key": "in-this-agreement", "type": "definition", "offset": [250, 267]}, {"key": "a-reference-to", "type": "clause", "offset": [284, 298]}, {"key": "member-state", "type": "clause", "offset": [325, 337]}], "samples": [{"hash": "etPWwrrTHhN", "uri": "/contracts/etPWwrrTHhN#emea", "label": "Sales, Distribution, and Development Agreement (Abbott Laboratories)", "score": 18.0, "published": true}, {"hash": "arBslziHIRi", "uri": "/contracts/arBslziHIRi#emea", "label": "Sales Contracts (Abbott Laboratories)", "score": 18.0, "published": true}, {"hash": "3gGID5jg4bm", "uri": "/contracts/3gGID5jg4bm#emea", "label": "Sales, Distribution, and Development Agreement (Supergen Inc)", "score": 18.0, "published": true}], "snippet": "means the European Medicines Evaluation Agency or any successor entity thereto in the European Union, provided that if submission for regulatory approval for the Product is made in the EU via the decentralized procedure, then reference to the \"EMEA\" in this Agreement shall be deemed a reference to the appropriate reference member state in the EU.", "size": 32, "hash": "99c96287a7ea1d7a2bd1ab97f0f0db64", "id": 5}, {"snippet_links": [{"key": "european-regulatory-authority", "type": "definition", "offset": [10, 39]}, {"key": "european-medicines-agency", "type": "definition", "offset": [53, 78]}, {"key": "successor-agency", "type": "clause", "offset": [87, 103]}], "samples": [{"hash": "aWJwoKBfSkh", "uri": "/contracts/aWJwoKBfSkh#emea", "label": "Collaboration and License Agreement (Isis Pharmaceuticals Inc)", "score": 25.848733902, "published": true}, {"hash": "65Tpka9XIGr", "uri": "/contracts/65Tpka9XIGr#emea", "label": "Collaboration and License Agreement (Alder Biopharmaceuticals Inc)", "score": 25.3285427094, "published": true}, {"hash": "hmRsDoxl6P3", "uri": "/contracts/hmRsDoxl6P3#emea", "label": "Collaboration and License Agreement (Alder Biopharmaceuticals Inc)", "score": 25.2108154297, "published": true}], "snippet": "means the European Regulatory Authority known as the European Medicines Agency and any successor agency thereto.", "size": 24, "hash": "cfcc1218b1e1451db825dbaf256d89fc", "id": 6}, {"snippet_links": [{"key": "middle-east-and-africa", "type": "clause", "offset": [18, 40]}], "samples": [{"hash": "iFh9D8bVtGQ", "uri": "https://investors.innovid.com/sec-filings/all-sec-filings/content/0001628280-22-013571/0001628280-22-013571.pdf", "label": "investors.innovid.com", "score": 17.0970058441, "published": false}, {"hash": "3ODWxgF7RMY", "uri": "https://investors.innovid.com/sec-filings/all-sec-filings/content/0001835378-22-000127/0001835378-22-000127.pdf", "label": "investors.innovid.com", "score": 11.302532196, "published": false}, {"hash": "kMVPsn5lNBi", "uri": "https://investors.innovid.com/sec-filings/all-sec-filings/content/0001835378-22-000126/0001835378-22-000126.pdf", "label": "investors.innovid.com", "score": 11.302532196, "published": false}], "snippet": "means Europe, the Middle East and Africa region;", "size": 18, "hash": "912770128dc7d08824c46cbc4b9aa4ab", "id": 7}, {"snippet_links": [{"key": "the-evaluation", "type": "clause", "offset": [30, 44]}, {"key": "medicinal-products", "type": "definition", "offset": [48, 66]}, {"key": "council-regulation", "type": "definition", "offset": [107, 125]}, {"key": "commission-regulation", "type": "definition", "offset": [182, 203]}], "samples": [{"hash": "dmIsujFHWdC", "uri": "/contracts/dmIsujFHWdC#emea", "label": "License Agreement (Acorda Therapeutics Inc)", "score": 22.5468864441, "published": true}, {"hash": "3FrrobTWrHr", "uri": "/contracts/3FrrobTWrHr#emea", "label": "License Agreement (Acorda Therapeutics Inc)", "score": 22.3497600555, "published": true}, {"hash": "hULdvjFgoVg", "uri": "/contracts/hULdvjFgoVg#emea", "label": "License Agreement (Acorda Therapeutics Inc)", "score": 21.0, "published": true}], "snippet": "means the European Agency for the Evaluation of Medicinal Products based in London (UK), as established by Council Regulation n\u00b0 2309/93 of July 22, 1993, as subsequently amended by Commission Regulation 649/98 of March 23, 1998.", "size": 17, "hash": "e1359915f229cf3ec111a5e3cb75d286", "id": 8}, {"snippet_links": [{"key": "evaluation-agency", "type": "definition", "offset": [29, 46]}, {"key": "successor-entity", "type": "clause", "offset": [56, 72]}], "samples": [{"hash": "krQywsjwAFz", "uri": "/contracts/krQywsjwAFz#emea", "label": "Exclusive License and Nonexclusive Option Agreement", "score": 31.3408622742, "published": true}, {"hash": "gv7jiouTn3A", "uri": "/contracts/gv7jiouTn3A#emea", "label": "Product Development and Commercialization Agreement", "score": 31.3408622742, "published": true}, {"hash": "2BHZqArWLuu", "uri": "/contracts/2BHZqArWLuu#emea", "label": "Research and Development Collaboration and License Agreement (Dynavax Technologies Corp)", "score": 25.1861743927, "published": true}], "snippet": "means the European Medicines Evaluation Agency, and any successor entity thereto.", "size": 16, "hash": "298a637b56f623d21388b9c9b641de5d", "id": 9}, {"snippet_links": [{"key": "the-evaluation", "type": "clause", "offset": [30, 44]}, {"key": "medical-products", "type": "definition", "offset": [48, 64]}, {"key": "from-time-to-time", "type": "clause", "offset": [110, 127]}], "samples": [{"hash": "gCvLMp78cqk", "uri": "/contracts/gCvLMp78cqk#emea", "label": "Licence and Distribution Agreement (Amarin Corp Plc\\uk)", "score": 20.0, "published": true}, {"hash": "8wg5WRzmxEL", "uri": "/contracts/8wg5WRzmxEL#emea", "label": "Licence and Distribution Agreement (Amarin Corp Plc\\uk)", "score": 20.0, "published": true}, {"hash": "6BnW5XPDyBv", "uri": "/contracts/6BnW5XPDyBv#emea", "label": "Licence Agreement (Amarin Corp Plc\\uk)", "score": 20.0, "published": true}], "snippet": "means the European Agency for the Evaluation of Medical Products or such successor or replacement body as may from time to time supersede it;", "size": 14, "hash": "a6b1fae743903cec36c8f0607356998b", "id": 10}], "next_curs": "ClESS2oVc35sYXdpbnNpZGVyY29udHJhY3Rzci0LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiINZW1lYSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "means the European Medicines Agency, or any successor agency thereto.", "size": 1274, "title": "EMEA", "id": "emea", "examples": ["Territory may be any one, and only one, of the following three geographic areas: Americas Territory, <strong>EMEA</strong> Territory or AsiaPac Territory each as defined below.", "The Canon Supplier Code of Conduct (\u201cCode\u201d) is set up by Canon <strong>EMEA</strong> in order to build Canon\u2019s business with all of its suppliers based on trust, teamwork, honesty and mutual respect.", "If Customer is in <strong>EMEA</strong>, this Agreement and all matters arising out of or in connection with it are governed by the substantive laws of England and Wales, without regard to that body of law known as conflicts of law and without regard to the United Nations Convention on Contracts for the Sale of Goods.", "For shipments within <strong>EMEA</strong> (i.e. originating in Ireland), title to and risk of loss passes to You at the Irish shipment point.", "This Order Form Supplement is being entered into between the \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587 entity named on the Order Form (either \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587, inc., \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587 Canada Corporation, Salesforce UK Limited (f/k/a \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587 <strong>EMEA</strong> Limited), \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587 France S.A.S., \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587 Germany GmbH, Salesforce Systems Spain, S.L.U., \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587 Italy S.r.l., SFDC Ireland Limited, Salesforce Tecnologia Ltda., \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587 Singapore Pte Ltd, or \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587 Kabushiki Kaisha) (&quot;\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587&quot;) and the Customer.", "Genesys has appointed \u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587, VP Cloud Competence Center &amp; Data Privacy <strong>EMEA</strong>, office phone +\u2587\u2587 (\u2587)\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587, mobile: +\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587, email address: \u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587\u2587\u2587@\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587 as Data Protection Officer.", "Telephone Numbers: Americas: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 <strong>EMEA</strong>: 44 (0) 203-608-0165 APAC: \u2587\u2587-\u2587-\u2587\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Problem Response and Resolution Conga will use commercially reasonable efforts to address Service Level Incidents in accordance with the schedule below.", "STRATEGIC ALLIANCE AGREEMENT BARTECH <strong>EMEA</strong> - HOTEL OUTSOURCE MANAGEMENT INT&#x27;L, INC.", "Support Call Logging Methods Australia: 1300 653 032 or +\u2587\u2587 \u2587 \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 Africa: +\u2587\u2587 \u2587\u2587 \u2587\u2587\u2587 \u2587\u2587\u2587\u2587 South America: Chile: +\u2587\u2587 \u2587 \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 Peru: +\u2587\u2587 \u2587\u2587\u2587 \u2587\u2587\u2587 \u2587\u2587\u2587 Brazil: +\u2587\u2587 \u2587\u2587 \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587 North America: +\u2587 \u2587\u2587\u2587 \u2587\u2587\u2587 \u2587\u2587\u2587\u2587 <strong>EMEA</strong> and CIS: +\u2587\u2587 \u2587\u2587\u2587\u2587 \u2587\u2587\u2587 \u2587\u2587\u2587 Email: \u2587\u2587\u2587\u2587\u2587\u2587\u2587@\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587 Web: \u2587\u2587\u2587\u2587\u2587://\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587\u2587\u2587\u2587.\u2587\u2587\u2587 Support Call Requirements \u2022 Users logging support calls must have attended Deswik Basic Training at a minimum.", "Item Details Deswik Support Office Asia Pacific \u2013 Brisbane, Perth South America \u2013 Santiago, Lima, Belo Horizonte North America \u2013 Calgary, Denver Africa \u2013 Johannesburg <strong>EMEA</strong> and CIS \u2013 London Service Days On Business Days \u2013 defined as day that is not a Saturday, Sunday or a public holiday in the location of Deswik\u2019s relevant Support Office (above)."], "related": [["ema", "EMA", "EMA"], ["pmda", "PMDA", "PMDA"], ["cfda", "CFDA", "CFDA"], ["maa", "MAA", "MAA"], ["fda", "FDA", "FDA"]], "related_snippets": [], "updated": "2026-02-13T05:59:08+00:00"}, "json": true, "cursor": ""}}